[{"ImageID": 0, "Page": 1, "Type": "Figure", "Imagebbox": [0.12361623616236163, 0.1635964891688544, 0.8929889298892989, 0.47069767441860466], "Caption": "Fig. 1. Exploring change in the US Federal Budget since 1970. The left panel shows the timelines of the actual budgets for each element in the tree: overall at the top, by Agency in the middle and by Bureau at the bottom. The StemView (center panel) compares 2013 and 2012. Each box in the StemView represents an element in the Budget. The green box on the top tells us that overall the Budget increased by US$7.81 Billion. The middle row shows the changes by Agency. Color represent the change in dollars (green for an increase)while the height of the boxes show the percentage of change. The width shows the budget in 2013. Defense, Health, Treasury and Social Security are the main players, and all are increasing.", "DPI": 100, "CaptionBB": [75, 521, 723, 599], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 1, "Page": 2, "Type": "Figure", "Imagebbox": [0.4987309644670051, 0.061395348837209304, 0.9467005076142132, 0.2483720930232558], "Caption": "Fig. 3. Types of tree comparison problems. Current literature has ad- dressed Types 0 and 1, with only one attempt at Type 3 [4]. TreeVersity2 supports all five cases, with emphasis on Types 1-4, the ones that in- clude node value changes.", "DPI": 100, "CaptionBB": [394, 282, 744, 334], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 2, "Page": 3, "Type": "Figure", "Imagebbox": [0.05166051660516605, 0.06778002493133752, 0.9606598984771574, 0.31348837209302327], "Caption": "Fig. 2. Different ways of showing changes between trees: (a) table representation, (b) bullet visualization, (c) treemap representation.", "DPI": 100, "CaptionBB": [42, 358, 694, 370], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 3, "Page": 5, "Type": "Figure", "Imagebbox": [0.04568527918781726, 0.06912955259665465, 0.9746192893401016, 0.4381395348837209], "Caption": "Fig. 4. National Cancer Institute Lung Cancer related death-rate change between 1999 and 2000 in the US. Color shows absolute change in the death-rate, while height represents the relative change (or percentage of change). The width encodes the population size for each group. The TimeBlocks show that the (a) overall rate increases only in 2000, however (b) the only race increasing is \"White\", that also happens to be more than 80% of the population. Among whites though, (c) women seem to be the ones contributing the most to the increase.", "DPI": 100, "CaptionBB": [42, 487, 756, 539], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 4, "Page": 5, "Type": "Figure", "Imagebbox": [0.05203045685279188, 0.532093023255814, 0.9746192893401016, 0.8967441860465116], "Caption": "Fig. 5. The Reporting tool on the right side. One of the report entries was selected, highlighting all the agencies and bureaus in the US Federal Budget that decreased the most (here more than $14 million dollars). Users can filter the display to show only those accounts by clicking on the corresponding line of text in the reporting tool.", "DPI": 100, "CaptionBB": [42, 980, 756, 1019], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 5, "Page": 7, "Type": "Figure", "Imagebbox": [0.05710659898477157, 0.5032558139534884, 0.9708121827411168, 0.813953488372093], "Caption": "Fig. 7. Sector Maps for the EBGM values of a non-disclosed drug for 2011 and 2010. Each box represents a type of adverse effect, with red values encoding high EBGM, which is \u201cbad\u201d. EBGM Values of the inner nodes cannot be seen, and could be exposed only by redrawing the Sector Map at a different level. FDA Analysts rely on side by side comparisons like this to identify changes effects of interest, then have to review differences for individual effects one by one.", "DPI": 100, "CaptionBB": [42, 894, 756, 946], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 6, "Page": 7, "Type": "Figure", "Imagebbox": [0.055350553505535055, 0.1433535741890973, 0.9746192893401016, 0.2762790697674419], "Caption": "Fig. 6. Steps of the StemView construction using a commonly used mapping for budget data: (a) First an icicle tree for the ending values is drawn, (b) then inside each level a horizon line is added to represent the no change reference. (c) Sub-boxes with height corresponding to the relative % change are drawn inside each node. (d) Finally the nodes are colored using the actual dollar amount of change.", "DPI": 100, "CaptionBB": [42, 313, 756, 352], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 7, "Page": 8, "Type": "Figure", "Imagebbox": [0.07360406091370558, 0.48372093023255813, 0.9098984771573604, 0.8148837209302325], "Caption": "Fig. 8. Changes in the FDA\u2019s EBGM index of adverse effects (e.g. Pulmonary Embolism) for the same drug between 2011 and 2010. Analysts were able to rapidly identify two major growing adverse effects in the context of other changes. We circled Deep Vein Thrombosis and Pulmonary Embolism (which was not even reported in 2010 as indicated by the thick white border indicating a create node). The EBGM index is distributed in a fixed, non-aggregated tree and it is a measure of how many more reports than expected are received for a certain adverse effect. Boxes going up from the no-change line are showing an adverse effect getting worse (boxes going down the effects that are reducing). The width of the boxes in the StemView represents the total number of reports, so wide boxes are more important. The color scale was specially customized to draw attention to the adverse effects whose indexes\u2019s confidence intervals did not overlap (shown in yellow to red). Therefore, analysts started with the wide, red boxes going up.", "DPI": 100, "CaptionBB": [29, 892, 743, 996], "first_confirmed": false, "second_confirmed": false}, {"ImageID": 8, "Page": 8, "Type": "Figure", "Imagebbox": [0.1065989847715736, 0.12651162790697673, 0.9428934010152284, 0.4055813953488372], "Caption": "Fig. 8. Changes in the FDA\u2019s EBGM index of adverse effects (e.g. Pulmonary Embolism) for the same drug between 2011 and 2010. Analysts were able to rapidly identify two major growing adverse effects in the context of other changes. We circled Deep Vein Thrombosis and Pulmonary Embolism (which was not even reported in 2010 as indicated by the thick white border indicating a create node). The EBGM index is distributed in a fixed, non-aggregated tree and it is a measure of how many more reports than expected are received for a certain adverse effect. Boxes going up from the no-change line are showing an adverse effect getting worse (boxes going down the effects that are reducing). The width of the boxes in the StemView represents the total number of reports, so wide boxes are more important. The color scale was specially customized to draw attention to the adverse effects whose indexes\u2019s confidence intervals did not overlap (shown in yellow to red). Therefore, analysts started with the wide, red boxes going up.", "DPI": 100, "CaptionBB": [29, 892, 743, 996], "first_confirmed": false, "second_confirmed": false}]